4//SEC Filing
Proniuk Stefan 4
Accession 0000914190-13-000350
CIK 0001195116other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 5:04 PM ET
Size
17.0 KB
Accession
0000914190-13-000350
Insider Transaction Report
Form 4
Proniuk Stefan
VP of Product Development
Transactions
- Other
Common Stock
2013-05-28$0.30/sh+1,289$387→ 3,955 total
Holdings
- 66,667
Series B Warrants (right to buy)
Exercise: $0.30From: 2012-11-26Exp: 2014-05-26→ Common Stock (66,667 underlying) - 57,534
Stock Option (right to buy)
Exercise: $0.30Exp: 2021-06-20→ Common Stock (57,534 underlying) - 55,000
Stock Option (right to buy)
Exercise: $0.30Exp: 2023-01-14→ Common Stock (55,000 underlying) - 18,333
Stock Option (right to buy)
Exercise: $0.30Exp: 2023-01-14→ Common Stock (18,333 underlying) - 66,667
8% Senior Convertible Debentures
Exercise: $0.30From: 2012-11-26Exp: 2015-11-26→ Common Stock (66,667 underlying) - 66,667
Series A Warrants (right to buy)
Exercise: $0.50From: 2012-11-26Exp: 2017-11-26→ Common Stock (66,667 underlying) - 137,500
Stock Option (right to buy)
Exercise: $0.30Exp: 2021-06-20→ Common Stock (137,500 underlying) - 80,000
Stock Option (right to buy)
Exercise: $0.30Exp: 2021-09-19→ Common Stock (80,000 underlying)
Footnotes (6)
- [F1]Shares issued in lieu of cash payment of liquidated damages in the amount of $387, pursuant to the terms of a Registration Rights Agreement dated November 26, 2012 among the Issuer and the investors identified therein, as amended on March 25, 2013.
- [F2]25% vested on 6/22/12 and thereafter in 24 equal monthy installments.
- [F3]On 6/22/2011, the Reporting Person was granted an option to purchase up to 112,500 shares of common stock of the Issuer. Up to 1/3 of the shares subject to the option may vest annually (or a pro rata portion thereof for a period of less than a full year) based on the achievement of certain performance milestones as determined by the Board of Directors (the 'Board') of the Issuer. On 1/17/2012, the Board determined that options for the prorated period ending 12/31/2011 would vest in the maximum potential amount of 20,034 shares. On 1/14/2013, the Board determined that options for the period ending 12/31/2012 would vest in the maximum potential amount of 37,500 shares.
- [F4]50% vested on 9/19/11 and thereafter in 24 equal monthly installments.
- [F5]1/3 vested on 1/14/13 and thereafter will vest in 24 equal monthy installments, commencing 1/31/13.
- [F6]On 1/14/2013, the Reporting Person was granted an option to purchase up to 55,000 shares of common stock of the Issuer. 1/3 of the shares subject to the option were immediately vested and up to 1/2 of the remaining shares subject to the option may vest annually, based on the achievement of certain performance milestones as determined by the Board.
Documents
Issuer
Arno Therapeutics, Inc
CIK 0001195116
Entity typeother
Related Parties
1- filerCIK 0001567873
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 5:04 PM ET
- Size
- 17.0 KB